Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (511-520 of 565) with videos related to

Pageof 57
Sort By:
The Journal of Bone and Joint Surgery. American Volume|July 24, 2024
Posterior Cervical Foraminotomy Compared with Anterior Cervical Discectomy with Fusion for Cervical Radiculopathy: Two-Year Results of the FACET Randomized Noninferiority StudyNádia F Simões de Souza, Anne E H Broekema, Michiel F Reneman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 23, 2019
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA TrialRudolf M Huber, Karin H Hansen, Luis Paz-Ares Rodríguez, et al.
European Radiology|September 4, 2014
Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON studyRichard A P Takx, Rozemarijn Vliegenthart, Firdaus A A Mohamed Hoesein, et al.
Clinical Lung Cancer|July 30, 2021
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the LiteratureBart Koopman, Harry J M Groen, Ed Schuuring, et al.
Plos Genetics|January 26, 2012
Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expressionJingyuan Fu, Marcel G M Wolfs, Patrick Deelen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2019
Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III studyW J A Witlox, B L T Ramaekers, M A Joore, et al.
Academic Radiology|March 11, 2020
Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative StudyYihui Du, Qiong Li, Grigory Sidorenkov, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinomaChristi M J Steendam, Robert Peric, Nico C van Walree, et al.
European Journal of Epidemiology|March 21, 2023
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trialGrigory Sidorenkov, Ralph Stadhouders, Colin Jacobs, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trialCornedine J de Gooijer, Vincent van der Noort, Jos A Stigt, et al.
Pageof 57

Showing results (511-520 of 565) with videos related to

Sort By:
Pageof 57
The Journal of Bone and Joint Surgery. American Volume|July 24, 2024
Posterior Cervical Foraminotomy Compared with Anterior Cervical Discectomy with Fusion for Cervical Radiculopathy: Two-Year Results of the FACET Randomized Noninferiority StudyNádia F Simões de Souza, Anne E H Broekema, Michiel F Reneman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 23, 2019
Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA TrialRudolf M Huber, Karin H Hansen, Luis Paz-Ares Rodríguez, et al.
European Radiology|September 4, 2014
Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON studyRichard A P Takx, Rozemarijn Vliegenthart, Firdaus A A Mohamed Hoesein, et al.
Clinical Lung Cancer|July 30, 2021
Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the LiteratureBart Koopman, Harry J M Groen, Ed Schuuring, et al.
Plos Genetics|January 26, 2012
Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expressionJingyuan Fu, Marcel G M Wolfs, Patrick Deelen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2019
Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III studyW J A Witlox, B L T Ramaekers, M A Joore, et al.
Academic Radiology|March 11, 2020
Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative StudyYihui Du, Qiong Li, Grigory Sidorenkov, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinomaChristi M J Steendam, Robert Peric, Nico C van Walree, et al.
European Journal of Epidemiology|March 21, 2023
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trialGrigory Sidorenkov, Ralph Stadhouders, Colin Jacobs, et al.
The Lancet. Respiratory Medicine|January 30, 2021
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trialCornedine J de Gooijer, Vincent van der Noort, Jos A Stigt, et al.
Pageof 57